Around the world, one of the major factors destroying lives and hampering economic growth is also one of the hardest to address. Non-communicable diseases (NCDs) — such as heart disease, diabetes and cancer — now account for two-thirds of all deaths worldwide.
In addition to cutting lives short, NCDs exact a massive economic toll on their victims, their families and their communities, sapping economic productivity and driving up medical costs. Over the next two decades, the total economic losses from NCDs could top US$30 trillion.
Addressing the complex challenge posed by NCDs requires a coordinated international effort. Fortunately, there have been some important steps in that direction.
Last month, the UN adopted the Sustainable Development Goals (SDG), a set of 17 objectives that are to guide the global development agenda for the next 15 years. Alongside targets like eliminating poverty and measures to protect the environment is a commitment to reducing mortality caused by NCDs — the first time the UN’s official development agenda has taken direct aim at the problem.
This is a welcome milestone, but it is only the first of many on a long road. The physical and economic burdens associated with NCDs fall the hardest where they are least easily borne: low and middle-income nations, where 80 percent of NCD-related deaths occur. Millions of people who have recently escaped poverty could be pushed back into it as a result.
The attention and peer pressure generated by the SDGs can help drive progress.
However, achieving the targets requires sustained focus, drawing on the resources and expertise of governments, international non-profit organizations and, crucially, the private sector.
Two important factors are likely to prove crucial in addressing the challenges posed by NCDs. Progress is likely to depend, first and foremost, on crafting effective local approaches that can be adapted, replicated and scaled up. There are no one-size-fits-all solutions to problems like diabetes or heart disease.
However, given that NCDs afflict communities in all parts of the world, there is much common ground that need not be continually rediscovered.
In 2013, for example, the Carlos Slim Foundation conducted a rigorous baseline assessment at eight primary-care clinics to understand the state of diabetes prevention and treatment. Based on the data gathered during the study, the Foundation piloted what is known as the CASALUD model to improve screening, treatment and prevention using low-cost, user-friendly devices that can measure a range of relevant vital signs, including blood glucose levels. Participating clinics have been equipped with an online system to track drug inventories and avoid shortages.
The approach was so effective that Mexico’s health office is using the CASALUD model as the basis for its national campaign to fight obesity, which can fuel diabetes and other NCDs — a great example of scaling up based on local experience.
The second key to success in the fight against NCDs is a commitment to tapping the resources of the private sector. This includes not only the mobilization of private investment, but also the deployment of the vast amounts of technical, operational and locally tailored expertise that private companies have gained in the course of doing business around the world.
By forming partnerships with governments, and international and domestic organizations, companies can help reduce the impact of devastating and costly diseases.
One company that is involved in such activities is the Lilly NCD Partnership. Its staff is cooperating with partners and the governments of India, Mexico, South Africa and Brazil to tackle NCDs. In Brazil, for example, the company is working closely with key local organizations, including the Federal University of Rio Grande do Sul, to improve disease prevention — with a focus on helping mothers who were diagnosed with gestational diabetes while pregnant and are now at risk of developing type 2 diabetes.
Such programs demonstrate what can be achieved through substantive, locally driven public-private partnerships around the world. Ensuring the success of the SDGs — including the reduction of mortality from NCDs — requires companies to move beyond traditional philanthropy and forge creative solutions to socioeconomic problems.
If people recognize that innovation stems from understanding local conditions and optimizing the vast resources of the private sector, it is possible to ensure better health — and more rapid economic growth — far into the future.
John Lechleiter is chairman, president and chief executive of Eli Lilly and Co.
Copyright: Project Syndicate
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Singaporean Prime Minister Lee Hsien Loong’s (李顯龍) decision to step down after 19 years and hand power to his deputy, Lawrence Wong (黃循財), on May 15 was expected — though, perhaps, not so soon. Most political analysts had been eyeing an end-of-year handover, to ensure more time for Wong to study and shadow the role, ahead of general elections that must be called by November next year. Wong — who is currently both deputy prime minister and minister of finance — would need a combination of fresh ideas, wisdom and experience as he writes the nation’s next chapter. The world that
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.
Since the Russian invasion of Ukraine in February 2022, people have been asking if Taiwan is the next Ukraine. At a G7 meeting of national leaders in January, Japanese Prime Minister Fumio Kishida warned that Taiwan “could be the next Ukraine” if Chinese aggression is not checked. NATO Secretary-General Jens Stoltenberg has said that if Russia is not defeated, then “today, it’s Ukraine, tomorrow it can be Taiwan.” China does not like this rhetoric. Its diplomats ask people to stop saying “Ukraine today, Taiwan tomorrow.” However, the rhetoric and stated ambition of Chinese President Xi Jinping (習近平) on Taiwan shows strong parallels with